Deerfield Management’s Melinta Therapeutics MLNT Stock Holding History
Bought
Maintained
Sold
Other funds holding MLNT
Deerfield Management's MLNT Position: Q2 2019 in Review
Deerfield Management sold out of Melinta Therapeutics (MLNT) in Q2 2019, closing a stake of 356,952 shares — an estimated $1.27M sold.
Deerfield Management first reported a position in MLNT in Q1 2018 and held it in 5 quarters. The position peaked at $25.4M in Q2 2018. 53 funds tracked by Wall St. Rank hold MLNT as of Q2 2019.
- Deerfield Management reported no remaining Melinta Therapeutics position as of Q2 2019 after selling out during the quarter.
- Deerfield Management sold 356,952 Melinta Therapeutics shares in Q2 2019, an estimated $1.27M.
- Deerfield Management first reported a position in Melinta Therapeutics in Q1 2018 and held it in 5 quarters.
- Deerfield Management's Melinta Therapeutics position peaked at $25.4M in Q2 2018.
- 53 funds tracked by Wall St. Rank held Melinta Therapeutics as of Q2 2019.
Based on Deerfield Management's 13F filing for Q2 2019, filed 14 Aug 2019.